
Scott Long
Examiner (ID: 7374, Phone: (571)272-9048 , Office: P/1633 )
| Most Active Art Unit | 1633 |
| Art Unit(s) | 1633 |
| Total Applications | 882 |
| Issued Applications | 557 |
| Pending Applications | 29 |
| Abandoned Applications | 301 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5237162
[patent_doc_number] => 20070129319
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-07
[patent_title] => 'Genes encoding human deubiquitinating enzymes'
[patent_app_type] => utility
[patent_app_number] => 10/579169
[patent_app_country] => US
[patent_app_date] => 2004-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 15793
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20070129319.pdf
[firstpage_image] =>[orig_patent_app_number] => 10579169
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/579169 | Genes encoding human deubiquitinating enzymes | Nov 11, 2004 | Abandoned |
Array
(
[id] => 4657096
[patent_doc_number] => 20080025957
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-31
[patent_title] => 'Stem Cells Suitable for Transplantation, their Preparation and Pharmaceutical Compositions Comprising Them'
[patent_app_type] => utility
[patent_app_number] => 10/578291
[patent_app_country] => US
[patent_app_date] => 2004-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 16384
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0025/20080025957.pdf
[firstpage_image] =>[orig_patent_app_number] => 10578291
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/578291 | Stem Cells Suitable for Transplantation, their Preparation and Pharmaceutical Compositions Comprising Them | Nov 7, 2004 | Abandoned |
Array
(
[id] => 22050
[patent_doc_number] => 07799563
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-09-21
[patent_title] => 'Carrier fiber assembly for tissue structures'
[patent_app_type] => utility
[patent_app_number] => 10/976952
[patent_app_country] => US
[patent_app_date] => 2004-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5474
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/799/07799563.pdf
[firstpage_image] =>[orig_patent_app_number] => 10976952
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/976952 | Carrier fiber assembly for tissue structures | Oct 28, 2004 | Issued |
Array
(
[id] => 7082671
[patent_doc_number] => 20050048051
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-03
[patent_title] => 'Method for controlled induction of somatic mutations and use thereof in proteomics'
[patent_app_type] => utility
[patent_app_number] => 10/499398
[patent_app_country] => US
[patent_app_date] => 2002-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5159
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20050048051.pdf
[firstpage_image] =>[orig_patent_app_number] => 10499398
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/499398 | Method for Controlled Induction of Somatic Mutations and Use Thereof in Proteomics | Oct 17, 2004 | Abandoned |
Array
(
[id] => 4658551
[patent_doc_number] => 20080027413
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-31
[patent_title] => 'Blood Products from Mesenchymal Stem Cells'
[patent_app_type] => utility
[patent_app_number] => 10/575961
[patent_app_country] => US
[patent_app_date] => 2004-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7619
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20080027413.pdf
[firstpage_image] =>[orig_patent_app_number] => 10575961
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/575961 | Blood Products from Mesenchymal Stem Cells | Oct 13, 2004 | Abandoned |
Array
(
[id] => 7106152
[patent_doc_number] => 20050107959
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-19
[patent_title] => 'Screening method for evaluation of bilayer-drug interaction in liposomal compositions'
[patent_app_type] => utility
[patent_app_number] => 10/956815
[patent_app_country] => US
[patent_app_date] => 2004-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 6491
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0107/20050107959.pdf
[firstpage_image] =>[orig_patent_app_number] => 10956815
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/956815 | Screening method for evaluation of bilayer-drug interaction in liposomal compositions | Sep 30, 2004 | Abandoned |
Array
(
[id] => 4866875
[patent_doc_number] => 20080145934
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-19
[patent_title] => 'Tissue-engineering scaffolds containing self-assembled-peptide hydrogels'
[patent_app_type] => utility
[patent_app_number] => 10/951357
[patent_app_country] => US
[patent_app_date] => 2004-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5284
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0145/20080145934.pdf
[firstpage_image] =>[orig_patent_app_number] => 10951357
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/951357 | Tissue-engineering scaffolds containing self-assembled-peptide hydrogels | Sep 27, 2004 | Issued |
Array
(
[id] => 5141267
[patent_doc_number] => 20070003483
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-04
[patent_title] => 'Method of evaluating organ function'
[patent_app_type] => utility
[patent_app_number] => 10/573062
[patent_app_country] => US
[patent_app_date] => 2004-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9310
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20070003483.pdf
[firstpage_image] =>[orig_patent_app_number] => 10573062
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/573062 | Method of evaluating organ function | Sep 27, 2004 | Abandoned |
Array
(
[id] => 4954497
[patent_doc_number] => 20080187521
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-07
[patent_title] => 'Use Of Medulliadrenal Chromaffin Cells Or Peptide Functional Cells'
[patent_app_type] => utility
[patent_app_number] => 11/576061
[patent_app_country] => US
[patent_app_date] => 2004-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4854
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0187/20080187521.pdf
[firstpage_image] =>[orig_patent_app_number] => 11576061
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/576061 | Use of medulliadrenal chromaffin cells or peptide functional cells | Sep 26, 2004 | Issued |
Array
(
[id] => 4988643
[patent_doc_number] => 20070154982
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-05
[patent_title] => 'Mammalian cell lines modified for the production of recombinant glycoproteins'
[patent_app_type] => utility
[patent_app_number] => 10/575051
[patent_app_country] => US
[patent_app_date] => 2004-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3811
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0154/20070154982.pdf
[firstpage_image] =>[orig_patent_app_number] => 10575051
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/575051 | Mammalian cell lines modified for the production of recombinant glycoproteins | Sep 26, 2004 | Abandoned |
Array
(
[id] => 5063600
[patent_doc_number] => 20070225240
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-27
[patent_title] => 'Screening Assay and Treatment'
[patent_app_type] => utility
[patent_app_number] => 10/581569
[patent_app_country] => US
[patent_app_date] => 2004-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 40
[patent_no_of_words] => 14420
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0225/20070225240.pdf
[firstpage_image] =>[orig_patent_app_number] => 10581569
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/581569 | Screening Assay and Treatment | Sep 12, 2004 | Abandoned |
Array
(
[id] => 5643220
[patent_doc_number] => 20060281675
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-14
[patent_title] => 'Somatogenic therapy using a 20kda placental variant of growth hormone'
[patent_app_type] => utility
[patent_app_number] => 10/568573
[patent_app_country] => US
[patent_app_date] => 2004-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 16663
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20060281675.pdf
[firstpage_image] =>[orig_patent_app_number] => 10568573
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/568573 | Somatogenic therapy using a 20kda placental variant of growth hormone | Aug 18, 2004 | Abandoned |
Array
(
[id] => 5001533
[patent_doc_number] => 20070044167
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-22
[patent_title] => 'Method for producing avian chimera using spermatogonial cells and avian chimera'
[patent_app_type] => utility
[patent_app_number] => 10/567815
[patent_app_country] => US
[patent_app_date] => 2004-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5879
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0044/20070044167.pdf
[firstpage_image] =>[orig_patent_app_number] => 10567815
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/567815 | Method for producing avian chimera using spermatogonial cells and avian chimera | Aug 10, 2004 | Abandoned |
Array
(
[id] => 5360994
[patent_doc_number] => 20090035788
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-05
[patent_title] => 'Genetically encoded bioindicators of calcium-ions'
[patent_app_type] => utility
[patent_app_number] => 10/567091
[patent_app_country] => US
[patent_app_date] => 2004-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 15527
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20090035788.pdf
[firstpage_image] =>[orig_patent_app_number] => 10567091
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/567091 | Genetically encoded bioindicators of calcium-ions | Aug 3, 2004 | Abandoned |
Array
(
[id] => 5100721
[patent_doc_number] => 20070183983
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-09
[patent_title] => 'Medical composition containing nf-kb decoy for treating and preventing respir atory diseases and method of using the same'
[patent_app_type] => utility
[patent_app_number] => 10/564269
[patent_app_country] => US
[patent_app_date] => 2004-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 16076
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0183/20070183983.pdf
[firstpage_image] =>[orig_patent_app_number] => 10564269
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/564269 | Medical composition containing nf-kb decoy for treating and preventing respir atory diseases and method of using the same | Jul 8, 2004 | Abandoned |
Array
(
[id] => 7261734
[patent_doc_number] => 20040241238
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-02
[patent_title] => 'Foamed sol-gel and method of manufacturing the same'
[patent_app_type] => new
[patent_app_number] => 10/479014
[patent_app_country] => US
[patent_app_date] => 2004-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 7084
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0241/20040241238.pdf
[firstpage_image] =>[orig_patent_app_number] => 10479014
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/479014 | Foamed sol-gel and method of manufacturing the same | Jul 6, 2004 | Abandoned |
Array
(
[id] => 5177531
[patent_doc_number] => 20070178591
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-02
[patent_title] => 'Internally administered therapeutic agents for diseases in central and peripheral nervous system comprising mesenchymal cells as an active ingredient'
[patent_app_type] => utility
[patent_app_number] => 10/562202
[patent_app_country] => US
[patent_app_date] => 2004-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 57
[patent_figures_cnt] => 57
[patent_no_of_words] => 28634
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0178/20070178591.pdf
[firstpage_image] =>[orig_patent_app_number] => 10562202
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/562202 | Internally administered therapeutic agents for diseases in central and peripheral nervous system comprising mesenchymal cells as an active ingredient | Jun 24, 2004 | Abandoned |
Array
(
[id] => 8282914
[patent_doc_number] => 08217016
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-07-10
[patent_title] => 'Application of mRNA for use as a therapeutic agent for tumorous diseases'
[patent_app_type] => utility
[patent_app_number] => 10/870110
[patent_app_country] => US
[patent_app_date] => 2004-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 16
[patent_no_of_words] => 18184
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 167
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10870110
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/870110 | Application of mRNA for use as a therapeutic agent for tumorous diseases | Jun 17, 2004 | Issued |
Array
(
[id] => 7144038
[patent_doc_number] => 20050118683
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-02
[patent_title] => 'Method for producing a polypeptide'
[patent_app_type] => utility
[patent_app_number] => 10/868373
[patent_app_country] => US
[patent_app_date] => 2004-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 11096
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0118/20050118683.pdf
[firstpage_image] =>[orig_patent_app_number] => 10868373
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/868373 | Method for producing a polypeptide | Jun 13, 2004 | Abandoned |
Array
(
[id] => 5153874
[patent_doc_number] => 20070036757
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-15
[patent_title] => 'Aav vector for gene therapy'
[patent_app_type] => utility
[patent_app_number] => 10/560268
[patent_app_country] => US
[patent_app_date] => 2004-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 6751
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0036/20070036757.pdf
[firstpage_image] =>[orig_patent_app_number] => 10560268
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/560268 | AAV vector for gene therapy | Jun 8, 2004 | Issued |